WEEKLY DOCETAXEL AS SECOND-LINE CHEMOTHERAPY IN ELDERLY PATIENTS (PTS) WITH ADVANCED/METASTATIC NONSMALL CELL LUNG CANCER (NSCLC): PRELIMINARY DATA OF A MONOCENTRIC EXPERIENCE


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles